Proceedings of the Special Committee on
Illegal Drugs
Issue 15 - Minutes
OTTAWA, Monday, March 18, 2002
(29)
[English]
The Special Committee on Illegal Drugs met this day in room 160-S, Centre Block, at 9:07 a.m., the Chair, the Honourable Senator Pierre Claude Nolin, presiding.
Members of the committee present: The Honourable Senators Banks, Maheu, Rossiter and Nolin (4).
In attendance: Director of Research: Daniel Sansfaçon; from the Library of Parliament: Gérald Lafrenière and Chantal Collin; from Newman Communications: Jean-Guy Desgagné and David Newman.
Also present: The official reporters of the Senate.
Pursuant to the Order of Reference adopted by the Senate on Thursday, March 15, 2001, the committee proceeded to study Canada's anti-drug legislation and policies. (See Issue No. 1, March 19, 2001, for the full text of the Order of Reference.)
WITNESSES:
From the University of Virginia:
Mr. William B. McAllister, Professor;
From the Department of Foreign Affairs and International Trade, International Crime Division:
Mr. Terry Cormier, Director;
Mr. Stephen Bolton, International Drug Officer.
Mr. McAllister made a statement and answered questions.
At 10:31 a.m., the committee suspended.
At 10:45 a.m., the committee resumed its hearing.
Mr. Cormier made a statement and, with Mr. Bolton, answered questions.
At 12:15 p.m., the committee adjourned to the call of the Chair.
ATTEST:
OTTAWA, Monday, March 18, 2002
(30)
[English]
The Special Committee on Illegal Drugs met this day in room 160-S, Centre Block, at 1:05 p.m., the Chair, the Honourable Senator Pierre Claude Nolin, presiding.
Members of the committee present: The Honourable Senators Banks, Maheu, Rossiter and Nolin (4).
In attendance: Director of Research: Daniel Sansfaçon; from the Library of Parliament: Gérald Lafrenière and Chantal Collin; from Newman Communications: Jean-Guy Desgagné and David Newman.
Also present: The official reporters of the Senate.
Pursuant to the Order of Reference adopted by the Senate on Thursday, March 15, 2001, the committee proceeded to study Canada's anti-drug legislation and policies. (See Issue No. 1, March 19, 2001, for the full text of the Order of Reference.)
WITNESS:
From the Inter-American Drug Abuse Control Commission:
Mr. David Beall, Executive Secretary.
Mr. Beall made a statement and answered questions.
At 2:35 p.m., the committee suspended.
At 2:43 p.m., the committee resumed its hearing, in camera, for the purposes of discussing a draft discussion paper.
It was agreed that the Chair would canvass members of the committee on a final version of the discussion paper and how to use the chart at the end of the paper.
At 3:18 p.m., the committee adjourned to the call of the Chair.
ATTEST:
Blair Armitage
Clerk of the Committee